Although a number of genes expressed in most tissues, including the liver, exhibit circadian regulation, gene expression profiles are usually examined only at one scheduled time each day. In this study, we investigated the effects of obese diabetes on the hepatic mRNA levels of various genes at 6-h intervals over a single 24-h period. Microarray analysis revealed that many genes are expressed rhythmically, not only in control KK mice but also in obese diabetic KK-A y mice. Real-time quantitative PCR verified that 19 of 23 putative circadianly expressed genes showed significant 24-h rhythmicity in both strains. However, obese diabetes attenuated these expression rhythms in 10 of 19 genes. More importantly, the effects of obese diabetes were observed throughout the day in only two genes. These results suggest that observation time influences the results of gene expression analyses of genes expressed circadianly.
Introduction
Many physiological and behavioral processes exhibit circadian, 24-h rhythmicity.
Recent studies have revealed that these endogenous rhythms are generated at the cellular level by circadian core oscillators, which are composed of transcriptional/translational feedback loops involving a set of clock genes [1, 2] . In mammals, rhythmic transcriptional enhancement by two basic helix-loop-helix Per-Arnt-Sim domain-containing transcription factors, CLOCK and brain and muscle Arnt-like protein 1 (BMAL1), provides the basic drive for the intracellular clock system; the CLOCK-BMAL1 heterodimer activates the transcription of various clock-controlled genes [3, 4] . Given that some clock-controlled genes, including the albumin D-site binding protein (Dbp), also serve as transcription factors, the expression of numerous genes may be tied to the molecular clock [1, 2] . In parallel, the CLOCK-BMAL1 heterodimer activates the transcription of the Period (PER) and Cryptochrome (CRY) genes [5] [6] [7] . When the PER and CRY proteins reach a critical concentration, they attenuate CLOCK-BMAL1 transactivation, thereby generating a circadian oscillation in their own transcription [4, 5] .
The molecular clock system resides not only in the hypothalamic suprachiasmatic nucleus, which is recognized as the mammalian central clock, but also in various peripheral tissues [8] [9] [10] . The suprachiasmatic nucleus is not essential for driving peripheral oscillations but acts as to synchronize peripheral oscillators [10] . Therefore, the local molecular clock may directly control the physiological rhythmicity in peripheral tissues.
Recent studies have suggested that malfunction of the molecular clock system is involved in the development of metabolic syndrome, which is a constellation of metabolic abnormalities including obesity, dyslipidemia, hypertension, and insulin resistance/type 2 diabetes [11] . In mice, inactivation of BMAL1 suppresses the diurnal variation in plasma glucose and triglyceride concentrations and can lead to insulin resistance [12] . Moreover, homozygous Clock mutant mice have an attenuated diurnal feeding rhythm, are hyperphagic and obese, and develop hyperglycemia, hyperlipidemia, and hepatic steatosis [13] . Furthermore, we have shown that the rhythmic expression of clock genes is attenuated in the liver and visceral adipose tissue of KK-A y mice, a genetic model of severe obesity and overt diabetes [14] . Liver and visceral adipose tissue have critical roles in the development of metabolic syndrome/type 2 diabetes [15, 16] . In the liver, approximately 10% of the genes are expressed circadianly, which may help maintain hepatic physiology [8, 9] . Therefore, the circadian expression of various genes appears to be dampened in the livers of animals with metabolic syndrome/type 2 diabetes.
In general, the in vivo effects of metabolic abnormalities on gene expression are studied at only one scheduled time each day. The effects of obese diabetes on the hepatic mRNA levels of several clock genes were observed only at their peak times [14] .
Therefore, differences in timing among experiments might cause diverse results, especially for genes expressed rhythmically. To test this hypothesis, we investigated the effects of obese diabetes on the hepatic mRNA levels of various genes at different times of day, using microarray and real-time quantitative PCR analyses.
Materials and methods

Mice
Female KK/Ta and KK-A y /Ta mice (n = 12 for each strain) were obtained from CLEA Japan (Tokyo, Japan) at 8 week of age and were maintained under specific pathogen-free conditions with controlled temperature and humidity and a 12-h light (07:00-19:00 h)/12-h dark (19:00-07:00 h) cycle. The mice were housed individually and were given a standard laboratory diet (CE-2; CLEA Japan) and water ad libitum. After 2 weeks, animals were sacrificed to obtain blood and liver samples at the following zeitgeber times 
Measuring circulating glucose and insulin concentrations
The blood glucose concentration was measured using a Glutest Ace R (Sanwa Kagaku Kenkyusyo, Nagoya, Japan). The radioimmunoassay for serum insulin was performed using kits purchased from Linco Research (St. Charles, MO). The intra-and interassay coefficients of variation were less than 10%.
RNA isolation and microarray hybridization
Total RNA was isolated from the liver samples using an RNeasy Mini kit (Qiagen, Valencia, CA). The amount and quality of RNA were assessed using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) and an Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA).
We used the samples obtained at ZT 0 and 12 for the microarray analysis because CLOCK-BMAL1 transcriptional activity peaks in the early dark phase and reaches a minimum in the early light phase [17] . Fragmented, biotin-labeled amplified cDNA was prepared from 85 ng of total RNA using the Ovation Biotin System (NuGEN Technologies, San Carlos, CA), which is powered by Ribo-SPIA technology [18] , according to the manufacturer's instructions. The cDNA (2.2 µg) was then hybridized to the GeneChip Mouse Expression Array 430A (Affymetrix, Santa Clara, CA), which contains 22,626
probe sets primarily against well-annotated full-length genes, for 18 h at 45°C. The chips were washed, and the signal was detected using standard Affymetrix reagents and protocols.
Analysis of the microarray data
A scanned image was quantified using GeneChip operating software, version 1.2 (Affymetrix) with the default parameters, and these data were analyzed using GeneSpring, version 7.2 (Agilent Technologies). Initially, values less than 0.01 were set to 0.01. After global normalization, each transcript was normalized to the median expression level across the samples obtained from KK mice at ZT 0. Statistical comparisons between groups were made using one-way ANOVA, and the transcripts that showed a significantly (P < 0.05) greater than 2-fold or less than 0.5-fold change were subjected to GeneTree clustering.
Quantitative reverse transcription-PCR
Reverse transcription was performed with 1.2 µg of total RNA, random hexamer primers, and RevertAid M-MuLV reverse transcriptase (Fermentas, Hanover, MD). The real-time quantitative PCR was performed with the ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA), as previously described [14, 19] . All specific primer sets and TaqMan probes were obtained from Applied Biosystems, and their
GenBank accession codes are shown in Table 1 . The data were analyzed using the comparative threshold cycle method [20] . To control the variation in the amount of DNA available for PCR in the different samples, the gene expression of the target sequence was normalized in relation to the expression of an endogenous control, glyceraldehyde-3-phosphate dehydrogenase.
Statistical analysis
Differences in circulating glucose and insulin concentrations between KK and KK-A y mice were determined using the Mann-Whitney U test. The rhythmicity of each gene was assessed using one-way ANOVA. Differences in the mRNA levels at each time point between groups were evaluated using Student's t-test. The values are presented as the means ± SEM, and P < 0.05 was considered significant. All calculations were performed using StatView, version 5.0 (SAS Institute, Cary, NC).
Results
Compared with KK mice, the strain with the A y allele (KK-A y ) developed severe obesity (KK, 28.9 ± 0.5 g; KK-A y , 43.5 ± 0.4 g; n = 12 in each strain; P < 0.01). Moreover, in KK-A y mice, marked hyperglycemia and hyperinsulinemia were observed throughout the day (Fig. 1) . Therefore, the KK-A y mice had developed obese type 2 diabetes by the time of the study.
The CLOCK-BMAL1 transcriptional activity peaks in the early dark phase and reaches a minimum in the early light phase [17] ; therefore, microarray analyses were performed using the samples obtained from both strains at ZT 0 and 12 (n = 3 in each of the four groups). We identified 343 transcripts whose levels differed significantly, by > 2-fold, among the groups (P < 0.05, one-way ANOVA) and subjected them to GeneTree clustering.
As expected, the 12 samples were divided correctly into the four groups (Fig. 2) . Note that this analysis next grouped KK mice at ZT 12 and KK-A y mice at ZT 12, rather than the same strains. These results suggest that the mRNA expression of many genes exhibits daily rhythmicity not only in KK mice but also in KK-A y mice. Moreover, as a whole, the observed gene expression was influenced more by the time at which the observation was made than by obese diabetes.
Then, we investigated whether obese diabetes affects the circadian expression of various genes. We selected those genes whose microarray expression levels differed by > 5-fold between ZT 0 and 12 in KK and KK-A y mice and analyzed their expression levels at ZT 0, 6, 12, and 18, using real-time quantitative PCR. As shown in Therefore, these results confirm that the mRNA expression of various genes exhibits 24-h rhythmicity, even in obese diabetic mice. As shown in Fig. 3 , the phases of the daily expression rhythms of all 19 circadianly expressed genes detected in this study did not seem to differ between the strains. However, obese diabetes significantly affected the mRNA levels of 13 rhythmically expressed genes at one or more observation time (Fig. 3A, B and C). In particular, the peak levels of ten genes were significantly attenuated in KK-A y mice compared with those in KK mice ( Fig. 3A and B) . The differences between the strains were observed throughout the day in only two of the 13 genes (Por and Depdc6) (Fig. 3A) . Therefore, obese diabetes dampened the rhythmic expression of various genes in the mouse liver, but these effects could be detected only at particular observation times in most of the genes.
Discussion
Previously, we showed that the rhythmic expression of the clock genes is attenuated in the liver of obese diabetic KK-A y mice compared with control KK mice [14] . Given that the molecular clock consisting of clock genes is thought to regulate most circadian gene expression [1, 2] , obese diabetes should attenuate the rhythmic expression of most genes. In this study, we found that the peak mRNA levels of more than half of the genes examined were reduced in the livers of KK-A y mice, whereas the transcript levels of about one-third of the genes examined were hardly affected throughout the day. Therefore, the influence of the molecular clock on rhythmic gene expression appears to vary among genes.
In concordance with previous results [14] , the peak transcript levels of the clock genes (Bmal1, Per3, and Dbp) in KK-A y mice were significantly lower than those in KK mice ( Fig. 3A and B) . By contrast, the mRNA level of neuronal PAS domain protein 2 (NPAS2), another clock gene, did not differ between the strains. NPAS2 is similar to CLOCK in amino acid sequence, and these transcription factors share BMAL1 as an obligate heterodimeric partner and bind to the same DNA recognition element [21] . The NPAS2-BMAL1 heterodimer, like CLOCK-BMAL1, is reported to play a role in maintaining circadian behaviors [22] . However, it remains unclear how NPAS2-BMAL1 affects the rhythmic gene expression in peripheral tissues. Moreover, whether obese diabetes affects the NPAS2-BMAL1 activity, as well as the CLOCK-BMAL1 action, remains to be determined.
Our results demonstrate that obese diabetes impairs the rhythmic expression of various genes, including Usp2, Upp2, Por, and Sphk2. Ubiquitin-specific protease 2, a preproteasomal isopeptidase, has been reported to stabilize fatty acid synthase [23] .
Hepatic uridine phosphorylase inversely regulates the circulating uridine level, and its circadian rhythmicity might be involved in the humoral control of sleep by uridine [24] .
Cytochrome P450 oxidoreductase transfers electrons to all microsomal P450 enzymes, and its deficiency can affect steroidogenesis and drug metabolism [25] . Sphingosine kinase is a key enzyme modulating the cellular levels of sphingolipids, which are involved in regulating multiple cellular processes, including cell growth, apoptosis, and proliferation [26] . Therefore, obese diabetes probably dampens the circadian rhythmicity of various physiological functions. Further studies are needed to clarify the pathophysiological roles of these effects in obese diabetes.
It has been suggested that approximately 10% of the genes expressed in the liver and about 8% of the genes expressed in the heart exhibit circadian regulation [9] . As most tissues, including the liver and heart, have an intracellular clock system [10, 27] , the expression of many genes in most organs is expected to exhibit rhythmicity. Our results strongly suggest that gene expression analysis based on observations at only one time of day would tend to overlook the effect of obese diabetes if the gene were to show rhythmic regulation. Therefore, the observed effects of obese diabetes, and possibly those of the other conditions, on many genes in various tissues might vary depending on the observation time. We suggest that circadian variation be considered in the analysis of in vivo gene expression. Using the microarray analysis, genes whose expression levels differed markedly (> 5-fold, P < 0.05) between ZT 0 and 12 in KK or KK-A y mice were selected, and their rhythmic mRNA expression was verified using the real-time PCR analysis. The rhythmicity of each gene was tested using one-way ANOVA. 
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